1Borriello, SP, Hammes, WP, Holzapfel, W, et al. (2003) Safety of probiotics that contain lactobacilli or bifidobacteria. Clin Infect Dis 36, 775–780.
2Bernardeau, M, Vernoux, JP, Henri-Dubernet, S, et al. (2008) Safety assessment of dairy microorganisms: the Lactobacillus genus. Int J Food Microbiol 126, 278–285.
3Cannon, JP, Lee, TA, Bolanos, JT, et al. (2005) Pathogenic relevance of Lactobacillus: a retrospective review of over 200 cases. Eur J Clin Microbiol Infect Dis 24, 31–40.
4Salminen, MK, Rautelin, H, Tynkkynen, S, et al. (2004) Lactobacillus bacteremia, clinical significance, and patient outcome, with special focus on probiotic L. rhamnosus GG. Clin Infect Dis 38, 62–69.
5Gasser, F (1994) Safety of lactic acid bacteria and their occurence in human clinical infections. Bull Inst Pasteur 92, 45–67.
6Salminen, MK, Tynkkynen, S, Rautelin, H, et al. (2002) Lactobacillus bacteremia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland. Clin Infect Dis 35, 1155–1160.
7Land, MH, Rouster-Stevens, K, Woods, CR, et al. (2005) Lactobacillus sepsis associated with probiotic therapy. Pediatrics 115, 178–181.
8Kunz, A & Farichok, MP (2004) Two cases of Lactobacillus bacteremia during probiotic treatment of short gut syndrome: the authors' reply. J Pediatr Gastroenterol Nutr 39, 437.
9Mackay, AD, Taylor, MB, Kibbler, CC, et al. (1999) Lactobacillus endocarditis caused by a probiotic organism. Clin Microbiol Infect 5, 290–292.
10Rautio, M, Jousimies-Somer, H, Kauma, H, et al. (1999) Liver abscess due to a Lactobacillus rhamnosus strain indistinguishable from L. rhamnosus strain GG. Clin Infect Dis 28, 1159–1160.
11Dekker, JW, Wickens, K, Black, PN, et al. (2009) Safety aspects of probiotic bacterial strains Lactobacillus rhamnosus HN001 and Bifidobacterium animalis subsp. animalis HN019 in human infants aged 0–2 years. Int Dairy J 19, 149–154.
12Kukkonen, K, Savilahti, E, Haahtela, T, et al. (2008) Long-term safety and impact on infection rates of postnatal probiotic and prebiotic (synbiotic) treatment: randomized, double-blind, placebo-controlled trial. Pediatrics 122, 8–12.
13Scalabrin, DM, Johnston, WH, Hoffman, DR, et al. (2009) Growth and tolerance of healthy term infants receiving hydrolyzed infant formulas supplemented with Lactobacillus rhamnosus GG: randomized, double-blind, controlled trial. Clin Pediatr (Phila) 48, 734–744.
14Salminen, MK, Tynkkynen, S, Rautelin, H, et al. (2004) The efficacy and safety of probiotic Lactobacillus rhamnosus GG on prolonged, noninfectious diarrhea in HIV patients on antiretroviral therapy: a randomized, placebo-controlled, crossover study. HIV Clin Trials 5, 183–191.
15Jacobsen, L, Wilcks, A, Hammer, K, et al. (2007) Horizontal transfer of tet(M) and erm(B) resistance plasmids from food strains of Lactobacillus plantarum to Enterococcus faecalis JH2-2 in the gastrointestinal of gnotobiotic rats. FEMS Microbiol Ecol 59, 158–166.
16Teuber, M, Meile, L & Schwarz, F (1999) Acquired antibiotic resistance in lactic acid bacteria from food. Antonie Van Leeuwenhoek 76, 115–137.
17Ammor, MS, Belen Florez, A & Mayo, B (2007) Antibiotic resistance in non-enterococcal lactic acid bacteria and bifidobacteria. Food Microbiol 24, 559–570.
18Dahl, KH, Mater, DD, Flores, MJ, et al. (2007) Transfer of plasmid and chromosomal glycopeptide resistance determinants occurs more readily in the digestive tract of mice than in vitro and exconjugants can persist stably in vivo in the absence of glycopeptide selection. J Antimicrob Chemother 59, 478–486.
19Saarela, M, Maukonen, J, von Wright, A, et al. (2007) Tetracycline susceptibility of the ingested Lactobacillus acidophilus LaCH-5 and Bifidobacterium animalis subsp. lactis Bb-12 strains during antibiotic/probiotic intervention. Int J Antimicrob Agents 29, 271–280.
20Mater, DD, Langella, P, Corthier, G, et al. (2008) A probiotic Lactobacillus strain can acquire vancomycin resistance during digestive transit in mice. J Mol Microbiol Biotechnol 14, 123–127.
22Vankerckhoven, V, Huys, G, Vancanneyt, M, et al. (2008) Biosafety assessment of probiotics used for human consumption: recommendations from the PROSAFE project. Trends Food Sci Technol 19, 102–114.
23Rosenfeldt, V, Benfeldt, E, Nielsen, SD, et al. (2003) Effect of probiotic Lactobacillus strains in children with atopic dermatitis. J Allergy Clin Immunol 111, 389–395.
24Tannock, GW, Munro, K, Harmsen, HJ, et al. (2000) Analysis of the fecal microflora of human subjects consuming a probiotic product containing Lactobacillus rhamnosus DR20. Appl Environ Microbiol 66, 2578–2588.
25Jacobsen, CN, Rosenfeldt Nielsen, V, Hayford, AE, et al. (1999) Screening of probiotic activities of forty-seven strains of Lactobacillus spp. by in vitro techniques and evaluation of the colonization ability of five selected strains in humans. Appl Environ Microbiol 65, 4949–4956.
26Verdenelli, MC, Ghelfi, F, Silvi, S, et al. (2009) Probiotic properties of Lactobacillus rhamnosus and Lactobacillus paracasei isolated from human faeces. Eur J Nutr 48, 355–363.
28Braat, H, van den Brande, J, van Tol, E, et al. (2004) Lactobacillus rhamnosus induces peripheral hyporesponsiveness in stimulated CD4+ T cells via modulation of dendritic cell function. Am J Clin Nutr 80, 1618–1625.
29Luyer, MD, Buurman, WA, Hadfoune, M, et al. (2005) Strain-specific effects of probiotics on gut barrier integrity following hemorrhagic shock. Infect Immun 73, 3686–3692.
30Hartemink, R & Rombouts, FM (1999) Comparison of media for the detection of bifidobacteria, lactobacilli and total anaerobes from faecal samples. J Microbiol Methods 36, 181–192.
31Hartemink, R, Domenech, VR & Rombouts, FM (1997) LAMVAB – a new selective medium for the isolation of lactobacilli from faeces. J Microbiol Methods 29, 77–84.
32Scardovi, V (1986) . In Bergey's Manual of Systematic Bacteriology, pp. 1418–1434 [Sneath, PHA, Mair, NS and Sharpe, ME, et al. , editors]. Baltimore, MD: Williams & Wilkins.
33Bakker-Zierikzee, AM, Alles, MS, Knol, J, et al. (2005) Effects of infant formula containing a mixture of galacto- and fructo-oligosaccharides or viable Bifidobacterium animalis on the intestinal microflora during the first 4 months of life. Br J Nutr 94, 783–790.
34Haarman, M & Knol, J (2006) Quantitative real-time PCR analysis of fecal Lactobacillus species in infants receiving a prebiotic infant formula. Appl Environ Microbiol 72, 2359–2365.
35Vancanneyt, M, Huys, G, Lefebvre, K, et al. (2006) Intraspecific genotypic characterization of Lactobacillus rhamnosus strains intended for probiotic use and isolates of human origin. Appl Environ Microbiol 72, 5376–5383.
36Klare, I, Konstabel, C, Muller-Bertling, S, et al. (2005) Evaluation of new broth media for microdilution antibiotic susceptibility testing of lactobacilli, pediococci, lactococci, and bifidobacteria. Appl Environ Microbiol 71, 8982–8986.
37Harty, DW, Oakey, HJ, Patrikakis, M, et al. (1994) Pathogenic potential of lactobacilli. Int J Food Microbiol 24, 179–189.
38Svedlund, J, Sjodin, I & Dotevall, G (1988) GSRS – a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci 33, 129–134.
39Whelan, K, Judd, PA & Taylor, MA (2004) Assessment of fecal output in patients receiving enteral tube feeding: validation of a novel chart. Eur J Clin Nutr 58, 1030–1037.
40Van Aerde, J, Alarcon, P, Lam, W, et al. (2003) Tolerance and safety of energy-dense enteral formulae for young children. Int Pediatr 18, 95–99.
41Makelainen, H, Tahvonen, R, Salminen, S, et al. (2003) In vivo safety assessment of two Bifidobacterium longum strains. Microbiol Immunol 47, 911–914.
42Choi, SS, Kang, BY, Chung, MJ, et al. (2005) Safety assessment of potential lactic acid bacteria Bifidobacterium longum SPM1205 isolated from healthy Koreans. J Microbiol 43, 493–498.
43Harty, DW, Patrikakis, M, Hume, EB, et al. (1993) The aggregation of human platelets by Lactobacillus species. J Gen Microbiol 139, 2945–2951.
44Hatakka, K, Holma, R, El-Nezami, H, et al. (2008) The influence of Lactobacillus rhamnosus LC705 together with Propionibacterium freudenreichii ssp. shermanii JS on potentially carcinogenic bacterial activity in human colon. Int J Food Microbiol 128, 406–410.